Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Journal of Medical Case Reports|March 20, 2013
Advanced small-cell colon carcinoma: a case reportToshiaki Iwase, Yoshinori Masuda, Takayuki Suzuki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 31, 2017
[Breast-Conserving Surgery Using Real-Time Virtual Sonography in a Breast Cancer Patient Who Received Neoadjuvant Chemotherapy - ACase Report]Junta Sakakibara, Masahiro Sakakibara, Takafumi Sangai, et al.
Expert Opinion on Therapeutic Targets|May 16, 2022
Emerging drug targets for triple-negative breast cancer: a guided tour of the preclinical landscapeXuemei Xie, Jangsoon Lee, Toshiaki Iwase, et al.
British Journal of Cancer|October 18, 2025
Reconsidering the definition of triple-negative breast cancer in the immune checkpoint inhibitor era: an optimal cut-off value for hormone receptor percentage of HER2-negative invasive breast cancerTakeo Fujii, Toshiaki Iwase, Yu Shen, et al.
Breast (Edinburgh, Scotland)|February 18, 2014
The effect of molecular subtype and body mass index on neo-adjuvant chemotherapy in breast cancer patientsToshiaki Iwase, Rikiya Nakamura, Naohito Yamamoto, et al.
Medicine|December 20, 2014
The relationship between skeletal-related events and bone scan index for the treatment of bone metastasis with breast cancer patientsToshiaki Iwase, Naohito Yamamoto, Hironori Ichihara, et al.
Breast Cancer Research and Treatment|January 21, 2021
Body composition and breast cancer risk and treatment: mechanisms and impactToshiaki Iwase, Xiaoping Wang, Tushaar Vishal Shrimanker, et al.
Cancer Treatment Reviews|May 27, 2025
Paving the path ForwARd: Advances and challenges in androgen receptor targeting in breast cancerNithya Sridhar, Toshiaki Iwase, Xuemei Xie, et al.
NPJ Breast Cancer|December 13, 2025
Racial and ethnic disparities in survival outcomes among patients with inflammatory breast cancer: a systematic review and meta-analysisChalothorn Wannaphut, Ben Ponvilawan, Toshiaki Iwase, et al.
Scientific Reports|February 15, 2025
Reassessing estrogen receptor expression thresholds for breast cancer prognosis in HER2-negative patients using shape restricted modelingWenli Dong, Takeo Fujii, Jing Ning, et al.
Pageof 4